CBS NewsHealth
FDA flags rare vision-loss risk from GLP-1 drugs
The Food and Drug Administration is adding a warning about rare reports of vision loss linked to glucagon-like peptide-1 medicines, including Ozempic and Wegovy. The agency says the potential side effect has been reported in some users.
This card is an AI-assisted summary of reporting published by CBS News. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.